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T
he plasma membrane undergoes 
dramatic shape changes during 
endocytosis. Starting off as an es-
sentially flat surface, the bilayer be-
comes increasingly curved before it fi  nally 
pinches off into the cytoplasm to form an 
endocytic vesicle. Numerous proteins coor-
dinate this process, many of which have 
been investigated by Harvey McMahon at 
the MRC Laboratory of Molecular Biology 
in Cambridge, UK.
McMahon fi  rst became interested in 
vesicles as a PhD student working on neuro-
transmitter release with David Nicholls at 
the University of Dundee (1). During his 
postdoc with Thomas Südhof at UT South-
western, McMahon studied the molecular 
mechanisms of synaptic vesicle fusion (2), 
but he switched his focus to the endocytic 
machinery upon starting his own lab in 
Cambridge. In addition to studying how 
endocytic cargo is recruited into nascent 
vesicles (3), McMahon has studied pro-
teins that sculpt the plasma membrane at 
every stage of endocytosis, 
from a membrane-shaping 
F-BAR protein that defi  nes 
the initial bud site (4) to the 
dynamin GTPase that releas-
es the completed vesicle into 
the cytoplasm (5). Many of 
these proteins contain a cres-
cent-shaped BAR domain (6). 
McMahon has also returned to exocytosis 
to study how membrane curvature drives 
vesicle fusion (7).
In a recent interview, McMahon dis-
cussed the arc of his career and how his 
future research is shaping up.
ON AN UPWARD CURVE
Where did you grow up?
I grew up in Ireland in a small town called 
Clones. So I guess at some level I was des-
tined to clone! I always wanted to know 
how things worked. I remember taking my 
grandfather’s pocket watch apart and not 
being able to put it back together again. 
During my time at university I started to 
think about how I could get paid to do some-
thing that I really liked doing. And so in my 
last year I applied for a research assistant’s 
post in David Nicholl’s lab that allowed me 
to study for a PhD at the same time.
What did you do during your PhD?
I showed that the neurotransmitter gluta-
mate was stored in vesicles and was released 
from these vesicles upon depolarization. I 
also worked on the effects of toxins like 
tetanus and botulinum toxins on the brain. 
That got me interested in molecular mecha-
nisms: I asked myself, “What are these tox-
ins actually targeting to shut down synaptic 
transmission?” So I moved to Tom Südhof’s 
lab at UT Southwestern for my postdoc, 
because he had his hands on many of the 
potential target proteins.
What did you discover during your time 
in Dallas?
I was isolating what we had termed the 
core complex in vesicle fusion, which 
turned out to be the same as Jim Rothman’s 
SNARE complex. It contained the three 
central components—syn-
taxin, SNAP-25, and synap-
tobrevin—and we showed 
that the complex was SDS 
resistant. But I found that 
there were other components 
associated with the complex 
that weren’t SDS resistant. 
That was the complexin 
family, and I worked on the complexins’ 
function in SNARE assembly and synaptic 
vesicle release.
I was also very interested in the hypoth-
esis that the machinery involved in synaptic 
vesicle fusion would be involved in fusing 
other types of vesicle and that there were 
ubiquitous versions of all of these synaptic 
proteins. I chose to look at synaptobrevin 
and ended up cloning its counterpart cellu-
brevin, which is involved in exocytosis 
throughout the body.
A BEND IN THE ROAD
Why did you switch to working on 
endocytosis in your own lab?
One reason was that we knew that you 
need to effi  ciently recycle synaptic vesicles 
in order to get further rounds of exocytosis. 
So we really wanted to look at the opposite 
side of the coin to vesicle release.
And ultimately that led to your interest 
in membrane bending…
Yeah. We started to look at components of 
clathrin-mediated endocytosis. I never liked 
the idea that a molecule such as clathrin, 
which doesn’t bind directly to membranes, 
could actually shape the membrane. It didn’t 
make sense to me from a biophysical stand-
point. So we decided to look at the direct 
membrane-binding proteins associated with 
clathrin-mediated endocytosis.
The fi  rst one we looked at was AP180, 
which caused a small level of membrane 
invagination in vitro. But when we looked 
at epsin it was much more startling. We 
crystallized epsin and found that it has an 
amphipathic helix that inserts into the bi-
layer to bend the membrane. It seemed 
inconceivable that epsin was the only pro-
tein doing this, so we went on to look at 
other molecules.
But our fi  ndings meant we could no 
longer think of membranes as a fl  uid mo-
saic of lipids and proteins; they must have 
a certain level of structure for the insertion 
of an amphipathic helix to bend them. So 
membranes are right at the fore of our 
thinking these days. We’ve recently gone 
back to exocytosis to ask what role mem-
branes play in that process as well. We now 
talk about curvature stress—the idea that 
membranes are stressed by proteins—and 
that this stores up energy that can drive 
membrane traffi  cking processes forward.
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McMahon studies how membranes are bent into shape during vesicle formation and fusion.
Harvey McMahon: Ahead of the curve on membrane dynamics
“There’s a 
reason each 
organelle is 
shaped the 
way it is.”
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You recently described a protein that 
acts at the very earliest step of clathrin-
mediated endocytosis…
If you want to make a clathrin-coated vesi-
cle, you have to start bending the membrane 
at a very early stage. To do that, you need a 
protein that can take a fl  at membrane and 
gradually mold it into something that’s much 
more curved, so it goes through a whole se-
ries of transitions. You should have a very 
strong phenotype if you knock out the pro-
tein that does that. But all the proteins we’d 
worked on in the past—epsins, amphi-
physins, and so on—showed relatively mild 
phenotypes when they were depleted.
So we turned our attention to the F-BAR 
family of membrane-shaping proteins and 
started doing structural biology on many of 
them. There was some serendipity here be-
cause the fi  rst one that crystallized was 
FCHo2, and that turned out to colocalize 
completely with clathrin-coated vesicles. It’s 
not actually incorporated into them, though, 
which is why people hadn’t found it before.
FCHo2 is a protein that binds to an al-
most fl  at membrane, and, as it concentrates 
itself, it achieves a much higher curvature. 
Then it twists on the membrane and achieves 
a higher curvature still. So it’s a protein that 
can adapt to a range of curvatures and there-
by promote the early stages of membrane 
invagination. When we decrease FCHo2 ex-
pression, we get less endocytosis, and, when 
we increase its expression, we get more.
How is vesicle budding coordinated with 
cargo recruitment?
What makes clathrin so unique is the fact 
that it has a central organizer—the AP2 
complex in the case of the plasma mem-
brane—and a whole series of accessory pro-
teins. We think that almost every clathrin 
accessory protein, if it interacts with and 
bends the membrane, will actually be a car-
go adapter as well. In other words, the cell 
doesn’t waste its time making proteins that 
bend the membrane without also bringing in 
cargo. So the whole thing integrates effi  -
ciently, and you can change the properties 
of the vesicle very easily by changing those 
accessory adapters in different cell types.
SHAPING THE FUTURE
Are there any principles that apply to 
all membrane-bending mechanisms?
Proteins that insert an amphipathic helix 
or some other domain into membranes 
tend to have a very strong effect on mem-
brane shape, whereas a protein that scaf-
folds the membrane from the outside has 
a much weaker effect unless the protein 
oligomerizes. But I wouldn’t call this a 
general principle because I think there are 
lots more possibilities. I actually think 
that we have only discovered the tip of the 
iceberg of proteins that affect membrane 
curvature. My feeling is that almost every 
membrane-binding protein, at some level, 
will infl  uence membrane shape.
What are you working on now?
We’re tremendously excited about clathrin-
independent endocytosis. There are many 
different entry routes into the cell. Are they 
connected to particular signaling events or 
traffi  cking to a particular compartment? 
We think that they are. One way to get a 
handle on these different routes is to under-
stand curvature. If you have a handle on 
the curvature mechanisms, you can modu-
late the pathways, as we can with FCHo2 
and clathrin-mediated endocytosis.
We’re still interested in the mechanisms 
of membrane fusion. We’re trying to take 
the same network approach that we used to 
understand clathrin-mediated endocytosis 
to understand how the many different pro-
teins involved in fusion can work together.
In general, although we’re beginning to 
understand how membranes and organelles 
are shaped, we are still intrigued about how 
this relates to function. Membranes aren’t 
just barriers—they all have shapes inher-
ent to every organelle. And that shape is 
important—there’s a reason each organ-
elle is shaped the way it is. We just haven’t 
fi  gured all those reasons out yet.
What is the Imagining the Brain project?
Imagining the Brain is a public engagement 
initiative that aims to inspire the talented 
cohort of young artists in Cambridge schools 
to communicate the latest thinking in sci-
ence, especially neuroscience. Yvonne Vallis 
from my lab gives talks on exciting topics to 
local schools, especially on subjects that the 
students say are really relevant to them. We 
put on a public exhibition of their artwork; 
the material from this initiative is being used 
all over the world, and examples are found 
on our web site (http://www.endocytosis
.org/ImaginingTheBrain/).
We are absolutely committed to encour-
aging young people to look at science in a 
new way, and the feedback we’ve had has 
been brilliant. In fact, I just got an email 
yesterday saying, “I just got accepted into 
Cambridge, having been enthused about 
science through you,” which is really great!
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The BAR domain of amphiphysin bends 
membranes, pulling out membrane tubules 
(green) in cells.
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“Scanning Beyond the Flesh,” a submission to 
the Imagining the Brain project.